Frank A. Holler, Director at Xenon Pharmaceuticals Inc. (XENE), sold 25,967 shares at $18.68 ($486K) on 2021-05-27, disclosed to the SEC on 2021-06-01.
Open-market sale of $486k XENE by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.68 | 8,485 | $158K | 32.6% |
| 2 | $18.68 | 8,485 | $159K | 32.6% |
| 3 | $18.69 | 2,579 | $48K | 9.9% |
| 4 | $18.88 | 507 | $10K | 2.0% |
| 5 | $18.88 | 5,911 | $112K | 22.9% |
| Total | $18.73 avg | 25,967 |
| $486K |
| 100% |
| Filing → |
| XENE | SELL | 2016-12-19 | $236K | — | Filing → |
| XENE | SELL | 2016-08-23 | $183K | — | Filing → |
| XENE | SELL | 2016-08-18 | $274K | — | Filing → |